Skip to main content

Advertisement

Table 4 Results from translation, divergent and concurrent validity evidence

From: Validity and reliability of the FSS in Greek MS patients

Study Translation Divergent Concurrent
   (patients vs non patients) FSS & Vitality FSS & PF FSS & BDI
MS Patients      
Present study OK Significant -0.72 -0.67 0.55
Armotlu et al. OK Significant - - 0.43
Azimian et al. OK Significant -0.69 -0.63 -
Valko et al. OK Significant - - -
Non MS Patients      
Katsarou et al. OK Significant -0.39 - 0.40
Ferentinos et al. OK Significant -0.52 - -  
Mattsson et al. OK Significant -0.63 - -
Kleinman et al. OK - -0.76 - -